By Jessica Thomas, LCSW Director of Patient Education, NETRF For many people living with neuroendocrine cancer, the journey begins with a singular focus: survival. A
By Anna C. Greene, PhD | NETRF Chief Scientific Officer In May, I attended the 2026 Small Cell Lung Cancer Consortium hosted by the National
Research-informed answers to your most important questions about neuroendocrine cancer. By Anna C. Greene, PhD, NETRF Chief Scientific Officer You asked. We’re answering. Through the
By Udhayvir Singh Grewal, MD GI/Neuroendocrine Medical Oncologist and Assistant Professor of Medical Oncology, Winship Cancer Institute of Emory University School of Medicine Dr. Grewal contributed
By Anna C. Greene, PhD, NETRF Chief Scientific Officer At the Neuroendocrine Tumor Research Foundation (NETRF), we fund research that can change how neuroendocrine cancers
Neuroendocrine neoplasms (NENs) can be difficult to detect, and many patients face long delays before receiving an accurate diagnosis. In many cases, NENs are not
By Carrie Camino, Member, NETRF Board of Directors Last month I had the extraordinary opportunity to attend the American Association of Cancer Research (AACR) as
By Anna C. Greene, PhD, NETRF Chief Scientific Officer The American Association for Cancer Research Annual Meeting, known as AACR, is one of the largest
Research-informed answers to your most important questions about neuroendocrine cancer. By Anna C. Greene, PhD, Chief Scientific Officer, Neuroendocrine Tumor Research Foundation (NETRF) You asked.
Leo Giancola lost his mom Ivette Giancola to neuroendocrine cancer when he was still in kindergarten. While his memories of her at that age are